Proto Labs: A Hidden Gem in Manufacturing Tech?

Harrison BrooksSaturday, Jun 21, 2025 9:10 am ET
69min read

Proto Labs (NYSE:PRLB), a leader in on-demand digital manufacturing and 3D printing, has long been a quiet force in the industry. Yet its stock price has lagged behind peers, creating an intriguing opportunity for investors. With a current valuation that may understate its potential, Proto Labs is positioned to capitalize on structural shifts in manufacturing—provided it can execute its growth strategy. Here's why the company could be primed for a comeback.

A Mixed Quarter, But Signs of Resilience

Proto Labs reported Q1 2025 revenue of $126.2 million, a 1.3% year-over-year decline but a beat on analyst estimates. While net income fell to $3.6 million, the company maintained profitability and outperformed expectations on EPS. The standout was its Protolabs Network, contributing $26.3 million in revenue—a 10% surge from 2024. This division, which connects customers with a global network of manufacturing partners, is proving to be a key growth lever.

The company's adjusted EBITDA dipped to $17.4 million (13.8% of revenue), reflecting margin pressures, but its balance sheet remains robust. With $116.3 million in cash and $20.9 million spent on buybacks this quarter, Proto Labs is prioritizing capital efficiency. Management also reaffirmed its focus on expanding production services beyond prototyping—a move aimed at tapping into the $300 billion global manufacturing market.

Valuation: A Discounted Asset with Upside

At $38.92 per share, Proto Labs trades at a significant discount to its average analyst price target of $44.33—a 13.9% potential upside. The GuruFocus fair value estimate of $39.05 suggests the stock is fairly priced, but this overlooks two critical factors:

  1. Network-driven growth: The Protolabs Network now accounts for 21% of total revenue, up from 17% in 2024. Its 10% YoY growth outpaces the broader business, and management has flagged it as a “high-margin, scalable engine.”
  2. Margin recovery potential: While Q1 margins dipped, operational improvements—such as automation in production and cost rationalization—are expected to stabilize EBITDA margins in the mid-teens by year-end.


The chart above highlights PRLB's underperformance relative to broader markets, which could present a buying opportunity as manufacturing demand stabilizes.

Catalysts for Growth: Beyond Prototyping

Proto Labs' long-term thesis hinges on two strategic shifts:
- Production services expansion: The company is transitioning from rapid prototyping to high-volume production, a move that could boost average order sizes. Its recent partnerships with automotive and medical device clients signal traction in this area.
- Global network scalability: The Protolabs Network reduces dependency on traditional manufacturing cycles, offering customers flexibility in an era of supply chain volatility. This model has already driven a 2.5% increase in revenue per customer contact despite a slight dip in total contacts.

Analysts project 4% annual revenue growth over the next two years, slightly above the U.S. machinery sector's 3.9% average. While near-term headwinds—such as cautious corporate spending—loom, Proto Labs' Q2 guidance ($124–132 million in revenue) is conservative enough to avoid missing estimates.

Risks to Consider

The company isn't without challenges. Its legacy prototyping business faces pricing pressures, and margin recovery depends on executing operational efficiencies. A prolonged softness in industrial demand could further compress profits.

The Bottom Line: A Buy for Patient Investors

Proto Labs trades at 14x trailing non-GAAP EPS, below its five-year average of 18x, even as it transitions into higher-margin markets. For investors willing to look past short-term noise, the stock offers asymmetric upside: a $44–$50 price target implies a 23% return at the high end, while downside risks are mitigated by its strong cash position and shareholder-friendly policies.

Investment advice: Consider accumulating PRLB on dips below $40, with a 12–18 month horizon. Pair this with a close watch on Q2 execution and margin trends. The undervaluation today may soon be corrected as the market recognizes its network-driven moat and production pivot.

This comparison underscores PRLB's ability to grow despite sector headwinds, a trend that could accelerate if its strategic bets pay off.